MicroRNA-3473b regulates the expression of TREM2/ULK1 and inhibits autophagy in inflammatory pathogenesis of

Qiankun Lv1, Zhen Zhong1, Binbin Hu1

  • 1Department of Neurology, the Second Affiliated Hospital of Nanchang University, Nanchang, China.

Journal of Neurochemistry
|January 15, 2021
PubMed

Insights

MicroRNA miR-3473b plays a key role in Parkinson disease (PD) by targeting TREM2 to regulate autophagy and reduce neuroinflammation. This suggests miR-3473b as a potential therapeutic target for PD treatment.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Parkinson disease (PD) involves dopaminergic neuron loss and neuroinflammation.
  • MicroRNAs (miRNAs) are implicated in PD pathogenesis.
  • TREM2 and ULK1 are crucial in microglial function and PD pathology.

Purpose of the Study:

  • To investigate the role of miR-3473b in Parkinson disease.
  • To elucidate the regulatory mechanism of miR-3473b involving TREM2 and ULK1.
  • To explore miR-3473b as a potential therapeutic target for PD.

Main Methods:

  • In vitro studies using BV2 microglia cells treated with LPS.
  • In vivo studies using MPTP-induced PD mouse models.
  • miR-3473b mimic and antagomir transfection, Western blotting, and dual-luciferase reporter assays.

Main Results:

  • miR-3473b inhibition reduced inflammatory factors and promoted autophagy in vitro and in vivo.
  • miR-3473b directly targets TREM2, and indirectly regulates ULK1 expression.
  • Upregulation of TREM2 increased p-ULK1, promoting autophagy and reducing inflammation.

Conclusions:

  • miR-3473b regulates neuroinflammation and autophagy in PD via the TREM2/ULK1 pathway.
  • Targeting miR-3473b offers a potential therapeutic strategy for Parkinson disease.
  • Modulating TREM2/ULK1 signaling through miR-3473b may ameliorate PD pathology.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.7K
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
41.9K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.2K